Trial Details
COMPLETEDBasic Information
| Clinical ID | c3235 |
|---|---|
| Identifier | NCT02351635 |
| Trial Title | BÜHLMANN fCAL™ ELISA - Aid in Differentiation of IBD From IBS |
| Trial URL | Visit Original Page |
Study Information
| Study Results | NO |
|---|---|
| Conditions | Inflammatory Bowel Disease|Irritable Bowel Syndrome |
| Interventions | OTHER: fecal calprotectin level |
Participant Information
| Sponsor | Bühlmann Laboratories AG |
|---|---|
| City | Palo Alto |
| Country/Region | United States |
Enrollment Criteria
| Sex Requirement | ALL |
|---|---|
| Age Requirement | ADULT, OLDER_ADULT |
Study Design
| Study Type | OBSERVATIONAL |
|---|---|
| Phase | NULL |
Time Information
| Start Date | 2015-01 |
|---|---|
| Primary Completion Date | 2018-03 |
| Completion Date | 2018-04 |